NEW: World Trade TARIFFS Simulator!
NEW: 2023 Data and Complexity Rankings
Sign In
Pricing

294120 (Harmonized System 1992 for 6-digit)

2023
World Trade $59.1MRnk 4276 / 4644
2023
Top Exporter | Top Importer $35.3M | $6.54MChina | India
2023
Product Complexity 1.4Rnk 240 / 4656
2022 - 2023
Export Growth (CAGR) -18.6%Rnk 3570 / 4644
2023
Share of World Trade 0.00026%Rnk 4276 / 4644

About

Overview This page contains the latest trade data of Streptomycins, derivatives, in bulk, salts. In 2023, Streptomycins, derivatives, in bulk, salts were the world's 4276th most traded product, with a total trade of $59.1M. Between 2022 and 2023 the exports of Streptomycins, derivatives, in bulk, salts decreased by -18.6%, from $72.5M to $59.1M. Trade in Streptomycins, derivatives, in bulk, salts represent 0.00026% of total world trade.

Streptomycins, derivatives, in bulk, salts are a part of Antibiotics.

Exports In 2023 the top exporters of Streptomycins, derivatives, in bulk, salts  were China ($35.3M), Netherlands ($8.01M), United States ($3.54M), France ($2.43M), and Germany ($2.04M).

Imports In 2023 the top importers of Streptomycins, derivatives, in bulk, salts were India ($6.54M), Saudi Arabia ($5.85M), Netherlands ($5.7M), United States ($3.94M), and Japan ($2.95M).

Ranking Streptomycins, derivatives, in bulk, salts ranks 240th in the Product Complexity Index (PCI).

Description Streptomycins are a group of antibiotic drugs that are used to kill bacteria. Streptomycins bind to the ribosomes of bacteria and inhibit protein synthesis. Streptomycin is also used to treat tuberculosis. Streptomycin derivatives, such as amikacin, gentamicin, kanamycin, neomycin, and tobramycin, are antibiotics that are used to treat various bacterial infections. Streptomycin salts are derivatives of streptomycin and are used to treat tuberculosis.

Latest Trends

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Streptomycins, derivatives, in bulk, salts. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2023)China$35.3M
Top Destination (2023)India$6.54M

In 2023 Streptomycins, derivatives, in bulk, salts were the world's 4276th most traded product (out of 4,644).

In 2023, the top exporters of Streptomycins, derivatives, in bulk, salts were China ($35.3M), Netherlands ($8.01M), United States ($3.54M), France ($2.43M), and Germany ($2.04M).

In 2023, the top importers of Streptomycins, derivatives, in bulk, salts were India ($6.54M), Saudi Arabia ($5.85M), Netherlands ($5.7M), United States ($3.94M), and Japan ($2.95M).

Explore Visualizations

Exporters of Streptomycins, derivatives, in bulk, salts (2023)
[Click to Select a Country]

Importers of Streptomycins, derivatives, in bulk, salts (2023)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2022 -  2023)Italy$1.81M
Top Destination Growth (2022 -  2023)Saudi Arabia$2.46M

Between 2022 and 2023, the exports of Streptomycins, derivatives, in bulk, salts grew the fastest in Italy ($1.81M), Netherlands ($1.31M), France ($733k), United Kingdom ($269k), and Denmark ($96.3k).

Between 2022 and 2023, the fastest growing importers of Streptomycins, derivatives, in bulk, salts were Saudi Arabia ($2.46M), Estonia ($599k), Mexico ($418k), Vietnam ($317k), and Israel ($169k).

Explore Visualizations

Exporters of Streptomycins, derivatives, in bulk, salts (2022 - 2023)

Importers of Streptomycins, derivatives, in bulk, salts (2022 - 2023)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Streptomycins, derivatives, in bulk, salts.

In 2023, market concentration measured using Shannon Entropy, was 2.24. This means that most of the exports of Streptomycins, derivatives, in bulk, salts are explained by 4 countries.

Explore Visualizations

Value of Exports in Streptomycins, derivatives, in bulk, salts

Net Trade

TOP NET EXPORTER (2023)China$33.2M
TOP NET IMPORTER (2023)India$5.68M

This map shows which countries export or import more of Streptomycins, derivatives, in bulk, salts. Each country is colored based on the difference in exports and imports of Streptomycins, derivatives, in bulk, salts during 2023.

In 2023, the countries that had a largest trade value in exports than in imports of Streptomycins, derivatives, in bulk, salts were China ($33.2M), Netherlands ($2.31M), Italy ($685k), Finland ($650k), and Germany ($57.2k).

In 2023, the countries that had a largest trade value in imports than in exports of Streptomycins, derivatives, in bulk, salts were India ($5.68M), Japan ($2.54M), Estonia ($2.11M), Belgium ($1.64M), and Spain ($1.6M).

Net Trade (2023)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Streptomycins, derivatives, in bulk, salts.
It is possible to select the main countries that export or import Streptomycins, derivatives, in bulk, salts in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Streptomycins, derivatives, in bulk, salts by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2023)

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms